Skip to content

Medical emergency? What to do

Geneticist First to Connect a Gene Central to Neuron Formation to Autism

3-RXPublished March 19, 20084 min read

Key points

  • Eli Hatchwell, M.D., Ph.D., Associate Professor of Pathology at Stony Brook University Medical Center, and colleagues have found that a disruption of the Contactin 4 gene on chromosome 3 may be linked to autism spectrum disorder (ASD).
  • “Given the prevalence of ASD, a clearer understanding of its etiology is necessary for both diagnostic and therapeutic purposes,” says Dr.
  • A whole genome analysis of the 92 subjects revealed that three subjects had chromosome 3 copy number variations that disrupted the same gene, Contactin 4.
  • The gene codes for an axon-associated cell adhesion molecule that is expressed in the brain and is known to be important in axonal development.

Eli Hatchwell, M.D., Ph.D., Associate Professor of Pathology at Stony Brook University Medical Center, and colleagues have found that a disruption of the Contactin 4 gene on chromosome 3 may be linked to autism spectrum disorder (ASD). What causes ASD, a developmental disorder of the central nervous system, is largely unknown. Dr. Hatchwell’s finding suggests that mutations affecting Contactin 4 may be relevant to ASD pathogenesis, and thus a potential biomarker for some individuals with the disorder. Details of the study are reported in the early online edition of the Journal of Medical Genetics.

According to the Centers for Disease Control and Prevention, the prevalence of ASD in the United States may be as high as 1 in 150 children. The disorder is divided into five subtypes, including autism proper. Pathogenesis of ASD may be environmental and/or biological. Experts suspect that many genes may play a role in the etiology of ASD.

“Given the prevalence of ASD, a clearer understanding of its etiology is necessary for both diagnostic and therapeutic purposes,” says Dr. Hatchwell, also Director of Stony Brook University’s Genomics Core Facility and Geneticist at the Cody Center for Autism and Developmental Disabilities at SBU. “Our study implicates Contactin 4 as a candidate gene in ASD, a finding that significantly contributes to our understanding of the biological basis of autism.”

A total of 92 patients with ASD from the Cody Center participated in the genetics study. The participants came from 81 families. Genomic DNA was analyzed from all subjects and, where relevant, from their biological parents. More than 500 normal control patients were included in the analysis.

A whole genome analysis of the 92 subjects revealed that three subjects had chromosome 3 copy number variations that disrupted the same gene, Contactin 4. A deletion was detected in two subjects (siblings), and a duplication was found in a third, unrelated, individual. Subsequent array analysis of parental DNA indicated that both variations were paternally inherited, specifically inherited from fathers without a history of ASD.

According to Dr. Hatchwell, when mutations are found that explain just one percent of a given ASD population, the results are significant, as ASD likely has a multitude of genetic causes. For example, a recent study reported in the New England Journal of Medicine showed that copy number variations of chromosome 16p11.2 accounted for one percent of all cases of the syndrome. Dr. Hatchwell explains that the genetic analysis with the Cody Center patients, detailed in the article entitled “Disruption of Contactin 4 in 3 Subjects with Autism Spectrum Disorder,” is highly significant in that two of 81 families (2.5 percent) presented with a disruption of Contactin 4.

The mutations found in Dr. Hatchwell’s study directly interrupt Contactin 4. The gene codes for an axon-associated cell adhesion molecule that is expressed in the brain and is known to be important in axonal development.

Dr. Hatchwell’s multidisciplinary research team is planning to analyze Contactin 4 in large numbers of patients with ASD and normal controls, in order to identify mutations that might be involved in the pathogenesis of ASD in a subset of affected individuals.

Dr. Hatchwell’s co-authors from Stony Brook University include: Jasmin Roohi, B.A., Department of Genetics; John C. Pomeroy, M.D., David H. Tegay, D.O., and Carla DeVincent, Ph.D., of the Department of Pediatrics; Lance E. Palmer, Ph.D., Department of Microbiology. Other authors include: Cristina Montagna, Ph.D., Department of Pathology and Molecular Genetics, Albert Einstein College of Medicine; Susan L. Christian, Ph.D., Department of Human Genetics, University of Chicago; and Norma Nowak, Ph.D., Department of Cancer Prevention and Population Sciences, University of Buffalo.

The study was supported in part by grants from the Cody Center for Autism and Developmental Disabilities, National Alliance for Autism Research, National Institute of Neurological Diseases and Stroke, the National Cancer Institute, and the General Clinical Research Center at SBUMC.

Source: Stony Brook University Medical Center

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Keep reading

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.